By Dr. Chinta Sidharthan New research reveals a sharp rise in metastatic breast cancer rates, highlighting how age, race, and ...

SAN ANTONIO -- The addition of palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy ...

Progression-free survival was superior with first-line maintenance of palbociclib in HR-positive, HER2-positive metastatic ...

Not only are they the smallest among us, but premature children also face health and life challenges that make them the most ...

The data include an interim look at the dose-escalation portion of a phase 2 trial assessing the adenosine A2A receptor ...

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast, according to 6-year data from the OlympiA trial.

Real-world study compares the efficacy and safety of axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel), ...

Children from low-income households are more likely to experience cancer relapse and face lower survival rates.

Adding pyrotinib to trastuzumab and docetaxel prolonged progression-free survival in patients with HER2-positive metastatic breast cancer.

Cardiff Oncology's phase 2 trial of onvansertib in mCRC shows promising results, with improved response rates and potential ...

"Golden Bachelor" star Gerry Turner announced he has bone marrow cancer. His form of bone marrow is considered to be ...

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative ...